Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,268
Closed -$999K 40
2024
Q4
$999K Sell
5,268
-173,994
-97% -$33.7M 0.08% 34
2024
Q3
$32.6M Sell
179,262
-1,357
-0.8% -$223K 2.41% 19
2024
Q2
$28.5M Buy
180,619
+23,881
+15% +$3.82M 2.05% 21
2024
Q1
$22.8M Sell
156,738
-163,043
-51% -$22.1M 2.58% 19
2023
Q4
$40.6M Buy
319,781
+27,764
+10% +$3.13M 4.88% 8
2023
Q3
$31M Buy
292,017
+161,087
+123% +$17.9M 4.17% 11
2023
Q2
$14.4M Buy
+130,930
New +$13M 1.9% 22

Other funds holding WAB

M.D. Sass LLC's WAB Position: Q1 2025 in Review

M.D. Sass LLC sold out of Wabtec (WAB) in Q1 2025, closing a stake of 5,268 shares — an estimated $999K sold.

M.D. Sass LLC first reported a position in WAB in Q2 2023 and held it in 7 quarters. The position peaked at $40.6M in Q4 2023. 1,037 funds tracked by Wall St. Rank hold WAB as of Q1 2025.

  • M.D. Sass LLC reported no remaining Wabtec position as of Q1 2025 after selling out during the quarter.
  • M.D. Sass LLC sold 5,268 Wabtec shares in Q1 2025, an estimated $999K.
  • M.D. Sass LLC first reported a position in Wabtec in Q2 2023 and held it in 7 quarters.
  • M.D. Sass LLC's Wabtec position peaked at $40.6M in Q4 2023.
  • 1,037 funds tracked by Wall St. Rank held Wabtec as of Q1 2025.

Based on M.D. Sass LLC's 13F filing for Q1 2025, filed 9 May 2025.